Entries by aaron

Omalizumab better treatment option for managing chronic spontaneous urticaria during pregnancy

Treating a pregnant patient with chronic spontaneous urticaria (CSU) can be quite challenging. According to recent findings, most CSU treatments for pregnant patients involved the use of second-generation H1-antihistamines (sgAHs), while information on the safety of Omalizumab is limited. A study found Omalizumab to be a safe treatment option for pregnant women with a history […]

Low-Dose Olanzapine Effectively Reduces chemotherapy induced vomiting in Cancer Patients

A recent study discovered that a lower dose of Olanzapine (OLZ) is just as effective as the standard dose for chemotherapy-induced nausea and vomiting (CINV), while it also significantly reduced daytime somnolence in cancer patients, The outcomes were presented in San Antonio Breast Cancer Symposium 2023. CINV poses a significant burden on cancer patients undergoing […]

Thiazolidinediones use reduces risk of rheumatoid arthritis in type 2 diabetes patients

China: A study published in Arthritis Care & Research by a team led by Houyu Zhao, PhD from the School of Public Health, Peking University, concluded that T2DM patients who use thiazolidinediones have a lower risk of developing rheumatoid arthritis. Thiazolidinediones (TZDs) have demonstrated a potential protective effect against rheumatoid arthritis (RA) in preclinical studies. […]

No need to panic, need to remain alert: AIIMS on new COVID subvariant JN.1

After a surge in the cases of the new COVID subvariant JN.1, doctors from the All India Institute of Medical Sciences (AIIMS) have advised people to not panic but rather remain alert and vigilant. “People are getting infected by the new sub-variant of COVID-JN.1 in many states of the country. The symptoms of the patients […]

NEXT now Mandatory after BAMS, BSMS, BUMS courses Regulations released

New Delhi: After MBBS and BDS, the National Exit Test (NExT) has also been mandatory for AYUSH courses. This has been confirmed in the newly introduced National Commission for Indian System of Medicine (National Examinations for Indian System of Medicine) Regulations, 2023, which were published in the Gazette notification dated 20.12.2023. The AYUSH NExT will be […]

Health Bulletin 25/December/2023

Here are the top health stories for the day: “No need to panic, need to remain alert”: AIIMS on new COVID subvariant JN.1 After a surge in the cases of the new COVID subvariant JN.1, doctors from the All India Institute of Medical Sciences (AIIMS) have advised people to not panic but rather remain alert […]

MUHS announces surprise inspection of nursing colleges January 2024 onwards

Maharashtra: The surprise inspection will commence from 22.01.2024 onwards for the grant of Continuation/Extension of Affiliation for Academic Year 2024-25 for nursing faculty, a recent notice by the  Maharashtra University of Health Sciences (MUHS) to all the nursing colleges has informed  The MUHS has also issued detailed guidelines related to the same. “The University has […]

Intas Pharma gets exclusive rights to commercialize Etanercept biosimilars in more than 150 countries across globe

Ahmedabad: Intas Pharmaceuticals Ltd., a multinational pharmaceutical company, has announced a strategic exclusive licensing agreement with mAbxience (a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma) for a biosimilar for Etanercept. Etanercept is a dimeric fusion protein with tumor necrosis factor (TNF) blocking action that was approved for use over 20 years ago, offering […]